Shoshana H. Ballew
A5078723203- Chronic Kidney Disease and Diabetes
- Dialysis and Renal Disease Management
- Peripheral Artery Disease Management
- Blood Pressure and Hypertension Studies
- Cerebrovascular and Carotid Artery Diseases
- Cardiovascular Health and Risk Factors
- Cardiovascular Health and Disease Prevention
- Cardiovascular Disease and Adiposity
- Renal and Vascular Pathologies
- Diabetes Treatment and Management
- Cardiovascular Function and Risk Factors
- Renal Diseases and Glomerulopathies
- Health Systems, Economic Evaluations, Quality of Life
- Acute Kidney Injury Research
- Diabetic Foot Ulcer Assessment and Management
- Diabetes Management and Research
- Lipoproteins and Cardiovascular Health
- Cardiac Imaging and Diagnostics
- Potassium and Related Disorders
- Health disparities and outcomes
- Heart Failure Treatment and Management
- Diagnosis and Treatment of Venous Diseases
- Parathyroid Disorders and Treatments
- Nutrition and Health in Aging
- Medication Adherence and Compliance
Johns Hopkins University
2016-2025
New York University
2023-2025
NYU Langone Health
2024
Bloomberg (United States)
2014-2023
Welch Foundation
2016-2023
Prognos (Switzerland)
2022
University of Pennsylvania
2021
Institute for Health Metrics and Evaluation
2017-2020
Mario Negri Institute for Pharmacological Research
2020
Istituti di Ricovero e Cura a Carattere Scientifico
2020
<h2>Summary</h2><h3>Background</h3> Health system planning requires careful assessment of chronic kidney disease (CKD) epidemiology, but data for morbidity and mortality this are scarce or non-existent in many countries. We estimated the global, regional, national burden CKD, as well cardiovascular gout attributable to impaired function, Global Burden Diseases, Injuries, Risk Factors Study 2017. use term CKD refer that can be directly attributed all stages we function additional risk from...
BackgroundThe Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment risk factor exposure attributable burden disease. By providing estimates over long time series, this study can monitor trends critical to health surveillance inform policy debates on the importance addressing risks in context.MethodsWe used comparative framework developed for previous iterations GBD estimate levels exposure, deaths, disability-adjusted life-years...
Current equations for estimated glomerular filtration rate (eGFR) that use serum creatinine or cystatin C incorporate age, sex, and race to estimate measured GFR. However, in eGFR is a social not biologic construct.
OBJECTIVE To test whether adding mobile application coaching and patient/provider web portals to community primary care compared with standard diabetes management would reduce glycated hemoglobin levels in patients type 2 diabetes. RESEARCH DESIGN AND METHODS A cluster-randomized clinical trial, the Mobile Diabetes Intervention Study, randomly assigned 26 practices one of three stepped treatment groups or a control group (usual care). total 163 were enrolled included analysis. The outcome...
BACKGROUND: Multivariable equations are recommended by primary prevention guidelines to assess absolute risk of cardiovascular disease (CVD). However, current have several limitations. Therefore, we developed and validated the American Heart Association Predicting Risk CVD EVENTs (PREVENT) among US adults 30 79 years age without known CVD. METHODS: The derivation sample included individual-level participant data from 25 sets (N=3 281 919) between 1992 2017. outcome was (atherosclerotic heart...
<h3>Importance</h3> Early identification of individuals at elevated risk developing chronic kidney disease (CKD) could improve clinical care through enhanced surveillance and better management underlying health conditions. <h3>Objective</h3> To develop assessment tools to identify increased CKD, defined by reduced estimated glomerular filtration rate (eGFR). <h3>Design, Setting, Participants</h3> Individual-level data analysis 34 multinational cohorts from the CKD Prognosis Consortium...
The burden of premature death and health loss from ESRD is well described. Less known regarding the cardiovascular disease attributable to reduced GFR. We estimated prevalence GFR categories 3, 4, 5 (not on RRT) for 188 countries at six time points 1990 2013. Relative risks outcomes by three were calculated pooled random effects meta-analysis. Results are presented as deaths disability-adjusted life years disease, 5, ESRD. In 2013, was associated with 4% worldwide, or 2.2 million (95%...
Background and objectives Billing codes are frequently used to identify AKI events in epidemiologic research. The goals of this study were validate billing code–identified against the current consensus definition ascertain whether sensitivity specificity vary by patient characteristic or over time. Design, setting, participants, & measurements population included 10,056 Atherosclerosis Risk Communities participants hospitalized between 1996 2008. was compared with 2012 Kidney Disease...
Concerns about hyperkalemia limit the use of angiotensin-converting enzyme inhibitors (ACE-I) and angiotensin receptor blockers (ARBs), but guidelines conflict regarding potassium-monitoring protocols. We quantified monitoring risks after ACE-I/ARB initiation developed validated a susceptibility score.We evaluated 69 426 new users therapy in Stockholm Creatinine Measurements (SCREAM) project with medication from January 1, 2007 to December 31, 2010, follow-up for 1 year thereafter. Three...
Little is known about the frequency and patterns of hyperkalemia in clinical settings. We evaluated association between baseline antihypertensive medications that may affect potassium levels (angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, β-blockers, loop/thiazide diuretics, potassium-sparing diuretics) hyperkalemia, defined by >5 mEq/L >5.5 mEq/L, over a 3-year time period 194 456 outpatients Geisinger Health System, as well actions taken after an episode...